Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This report reviews various presumptive factors contributing to diffuse hair loss in women, emphasizing the need for comprehensive assessment to identify potential underlying causes; it presents no new clinical results.

This study found that increased atypical club hair observed in microscopic hair examinations may be characteristic of telogen effluvium compared to healthy individuals and diffuse alopecia areata patients.

This study found that multiple factors, including psychological stress, fever, childbirth, and surgeries, may contribute to telogen effluvium and hair loss in women, with appropriate treatment normalizing hair loss.

In this study, the authors compared trichoscopy findings for different forms of diffuse non-cicatricial alopecia in females and suggested that trichoscopy might often replace the need for histopathological confirmation, reserving biopsies for more uncertain cases.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

This case report describes a 2-year-old boy in critical condition who developed anagen effluvium, possibly due to hypotension and hypoxia triggering hair follicle apoptosis.

This study found that the TrichoScan software effectively differentiated between androgenetic alopecia and telogen effluvium in women with diffuse hair loss, aligning with clinical diagnoses.

This study suggests that low serum iron and ferritin levels may be associated with telogen effluvium in patients presenting with hair loss.

This study reports that telogen effluvium prevalence after childbirth may be higher in women who are multiparous, have had a cesarean section, experienced greater weight gain, or gave birth after 38 weeks.

This study found that women with telogen effluvium had significantly lower serum ferritin levels compared to healthy controls, suggesting an association between iron deficiency and this form of hair loss.

This case report highlights the importance of considering telogen effluvium in young men with hair loss resembling male androgenetic alopecia to prevent misdiagnosis and unnecessary treatment.

In this case report, the researchers documented a rare instance of plica neuropathica, characterized by matted and twisted hair, occurring alongside diffuse alopecia, marking the first such documented association and emphasizing its diagnostic challenges in identifying causes of alopecia.

In this article, the authors concluded that despite diverse causes of diffuse hair loss, modern therapies can effectively manage the condition without side effects, as demonstrated in two clinical cases of telogen effluvium.

In this case report, azathioprine induced sudden hair loss and pancytopenia in a 42-year-old female patient, but discontinuing the drug and providing supportive care resulted in complete recovery and hair regrowth within 2.5 months.

This article reviews the causes and pathogenesis of telogen effluvium, a prevalent form of hair loss, but reports no new research findings.

This review discusses the complex diagnosis and management of telogen effluvium, noting its high prevalence, psychosocial impact, and need for quantitative diagnostic techniques, but it reports no new research findings.

Telogen effluvium hair loss often resolves on its own in 3 to 6 months, but see a dermatologist if it persists.

This study found that among Pakistani patients with diffuse hair fall, a significant 79.17% had vitamin D3 deficiency, suggesting that early recognition and treatment of this deficiency may help reduce hair loss.

This report describes a case where dermoscopy of shed hair helped diagnose post-COVID acute telogen effluvium by revealing depigmented club-shaped bulbs, highlighting its potential as a noninvasive diagnostic tool.

This study found that low ferritin levels are associated with higher telogen ratios in women with diffuse hair loss, suggesting an important role of ferritin in telogen effluvium diagnosis.

This review discusses anticoagulant and antihypertensive medications as potential contributors to medication-induced telogen effluvium and reports no new clinical results.

The abstract notes that while telogen effluvium—a condition causing diffuse hair loss—is triggered by stressors like significant weight loss, there is limited literature specifically exploring the connection between telogen effluvium and weight loss.

This study found that childbearing women with telogen effluvium had significantly lower ferritin levels compared to healthy controls, and observed a strong inverse correlation between ferritin levels and the amount of hair shed, suggesting low iron stores may contribute to hair loss.

This observational study in middle-aged women aimed to evaluate the efficacy and safety of omega-3 fatty acids in treating telogen effluvium, but results specific to these outcomes were not provided.

In this study, serum zinc levels in telogen effluvium patients showed no significant difference compared to healthy controls.

This study found that dermoscopy can help differentiate between types of diffuse alopecia in females, with yellow dots common in telogen effluvium and hair diameter diversity over 20% significant in female androgenetic alopecia.

This review discusses the causes, diagnosis, and treatment approaches for telogen effluvium but presents no new clinical findings; novel treatments like ALRV5XR are highlighted as promising.

This study found that treating diffuse alopecia associated with prior COVID-19 infection using a combination of Selencin (homeopathic drug) and Selencin Peptide Active (peptide lotion) significantly reduced hair loss and improved hair structure and volume in 34 patients over two months.

This review discusses telogen effluvium in women and suggests that combining minoxidil with supplementary therapies may enhance treatment outcomes, but it reports no new clinical results.

In this study, women with diffuse hair loss reported that Proteoglycan Replacement Therapy with Nourkrin® improved hair growth and appearance, boosting their confidence and satisfaction with the treatment.